Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
Cancer Res Commun
; 3(8): 1486-1500, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37559947
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostaglandins
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Res Commun
Year:
2023
Type:
Article